Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
23.66
0.00 (0.00%)
At close: May 6, 2026

SHE:001367 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
520.39531.67470.54396.28421.14386.79
Other Revenue
0.590.590.971.171.642.19
520.97532.26471.51397.45422.78388.98
Revenue Growth (YoY)
9.87%12.88%18.63%-5.99%8.69%36.58%
Cost of Revenue
280.68291.24281.91237.4266.52236.12
Gross Profit
240.29241.02189.6160.05156.26152.87
Selling, General & Admin
52.852.2440.6535.7232.2532.94
Research & Development
38.8238.8627.7818.8415.7712.07
Other Operating Expenses
5.244.584.364.162.133.11
Operating Expenses
99.5898.4172.8859.1551.2447.85
Operating Income
140.71142.61116.72100.9105.02105.02
Interest Expense
-0.35-0.35-0.37-0.03-0.07-0.1
Interest & Investment Income
11.7610.718.4115.623.552.25
Currency Exchange Gain (Loss)
-0.05-0.053.320.878.37-2.17
Other Non Operating Income (Expenses)
-2.43-0.28-0.24-0.190.05-0.4
EBT Excluding Unusual Items
149.64152.62137.85117.17116.93104.59
Gain (Loss) on Sale of Investments
1.71.7---3.850.74
Gain (Loss) on Sale of Assets
----0.24--
Asset Writedown
-0.45-0.4-1.23-0.96-1.21-0.67
Other Unusual Items
2.842.845.114.7111.913.86
Pretax Income
153.72156.76141.79120.68123.78108.52
Income Tax Expense
20.1520.8819.2316.0116.1914.52
Net Income
133.58135.88122.56104.67107.5994
Net Income to Common
133.58135.88122.56104.67107.5994
Net Income Growth
10.96%10.87%17.09%-2.72%14.46%49.62%
Shares Outstanding (Basic)
150149149137112112
Shares Outstanding (Diluted)
152153149137112112
Shares Change (YoY)
0.43%2.15%9.03%22.74%-0.02%-
EPS (Basic)
0.890.910.820.760.960.84
EPS (Diluted)
0.880.890.820.760.960.84
EPS Growth
10.48%8.54%7.40%-20.74%14.68%49.60%
Free Cash Flow
48.925.19102.4123.1754.7673.72
Free Cash Flow Per Share
0.320.170.690.170.490.66
Dividend Per Share
0.1160.1160.1700.228--
Dividend Growth
-31.77%-31.77%-25.50%---
Gross Margin
46.12%45.28%40.21%40.27%36.96%39.30%
Operating Margin
27.01%26.79%24.75%25.39%24.84%27.00%
Profit Margin
25.64%25.53%25.99%26.33%25.45%24.16%
Free Cash Flow Margin
9.38%4.73%21.72%5.83%12.95%18.95%
EBITDA
163.97164.28132.04113.52118.59117.37
EBITDA Margin
31.47%30.87%28.00%28.56%28.05%30.17%
D&A For EBITDA
23.2721.6815.3212.6213.5612.35
EBIT
140.71142.61116.72100.9105.02105.02
EBIT Margin
27.01%26.79%24.75%25.39%24.84%27.00%
Effective Tax Rate
13.11%13.32%13.56%13.26%13.08%13.38%
Revenue as Reported
532.26532.26471.51397.45422.78388.98
Source: S&P Global Market Intelligence. Standard template. Financial Sources.